Chemical, spectroscopic, or microscopic detection of extremely small amounts of blood.
Endoscopic examination, therapy or surgery of the luminal surface of the colon.
Resin from wood of certain species of GUAIACUM. It is used as clinical reagent for occult blood.
Endoscopic examination, therapy or surgery of the sigmoid flexure.
Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI.
Organized periodic procedures performed on large groups of people for the purpose of detecting disease.
Methods to identify and characterize cancer in the early stages of disease and predict tumor behavior.
A compound used as an x-ray contrast medium that occurs in nature as the mineral barite. It is also used in various manufacturing applications and mixed into heavy concrete to serve as a radiation shield.
A solution or compound that is introduced into the RECTUM with the purpose of cleansing the COLON or for diagnostic procedures.
Field of chemistry that pertains to immunological phenomena and the study of chemical reactions related to antigen stimulation of tissues. It includes physicochemical interactions between antigens and antibodies.
The black, tarry, foul-smelling FECES that contain degraded blood.
A benign epithelial tumor with a glandular organization.
Discrete tissue masses that protrude into the lumen of the COLON. These POLYPS are connected to the wall of the colon either by a stalk, pedunculus, or by a broad base.
Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed)
Excrement from the INTESTINES, containing unabsorbed solids, waste products, secretions, and BACTERIA of the DIGESTIVE SYSTEM.
Bleeding in any segment of the GASTROINTESTINAL TRACT from ESOPHAGUS to RECTUM.
Commercially prepared reagent sets, with accessory devices, containing all of the major components and literature necessary to perform one or more designated diagnostic tests or procedures. They may be for laboratory or personal use.
A non-invasive imaging method that uses computed tomographic data combined with specialized imaging software to examine the colon.
Tumors or cancer of the RECTUM.
Tests used in the analysis of the hemic system.
Very toxic industrial chemicals. They are absorbed through the skin, causing lethal blood, bladder, liver, and kidney damage and are potent, broad-spectrum carcinogens in most species.
Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant & Hackh's Chemical Dictionary, 5th ed, p301, p499)
Voluntary cooperation of the patient in following a prescribed regimen.
A member of the S-100 protein family that is present at high levels in the blood and interstitial fluid in several infectious, inflammatory, and malignant disorders, including rheumatoid arthritis, inflammatory bowel disease, and cystic fibrosis. It is a complex of a light chain (CALGRANULIN A) and a heavy chain (CALGRANULIN B). L1 binds calcium through an EF-hand motif, and has been shown to possess antimicrobial activity.
Tumors or cancer of the COLON.
Positive test results in subjects who do not possess the attribute for which the test is conducted. The labeling of healthy persons as diseased when screening in the detection of disease. (Last, A Dictionary of Epidemiology, 2d ed)
The seeking and acceptance by patients of health service.
The functions and activities carried out by the U.S. Postal Service, foreign postal services, and private postal services such as Federal Express.
In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test.
Systems used to prompt or aid the memory. The systems can be computerized reminders, color coding, telephone calls, or devices such as letters and postcards.
The simultaneous use of multiple laboratory procedures for the detection of various diseases. These are usually performed on groups of people.
Immunologic techniques involved in diagnosis.
A genus of nematode worms comprising the whipworms.
The oxygen-carrying proteins of ERYTHROCYTES. They are found in all vertebrates and some invertebrates. The number of globin subunits in the hemoglobin quaternary structure differs between species. Structures range from monomeric to a variety of multimeric arrangements.
I'm sorry for any confusion, but "Philippines" is not a medical term; it is the name of a country located in Southeast Asia. It seems there might be some misunderstanding in your question. If you have a medical query related to the Philippines or its people, I'd be happy to help clarify that for you.
A method of comparing the cost of a program with its expected benefits in dollars (or other currency). The benefit-to-cost ratio is a measure of total return expected per unit of money spent. This analysis generally excludes consideration of factors that are not measured ultimately in economic terms. Cost effectiveness compares alternative ways to achieve a specific set of results.
Negative test results in subjects who possess the attribute for which the test is conducted. The labeling of diseased persons as healthy when screening in the detection of disease. (Last, A Dictionary of Epidemiology, 2d ed)
Pathological processes in the COLON region of the large intestine (INTESTINE, LARGE).
The term "United States" in a medical context often refers to the country where a patient or study participant resides, and is not a medical term per se, but relevant for epidemiological studies, healthcare policies, and understanding differences in disease prevalence, treatment patterns, and health outcomes across various geographic locations.
A subspecialty of internal medicine concerned with the study of the physiology and diseases of the digestive system and related structures (esophagus, liver, gallbladder, and pancreas).

Faecal occult blood screening and reduction of colorectal cancer mortality: a case-control study. (1/590)

To estimate the efficacy of screening on colorectal cancer mortality, a population-based case-control study was conducted in well-defined areas of Burgundy (France). Screening by faecal occult blood test prior to diagnosis in cases born between 1914 and 1943 and who died of colorectal cancer diagnosed in 1988-94 was compared with screening in controls matched with the case for age, sex and place of residence. Cases were less likely to have been screened than controls, with an odds ratio (OR) of 0.67 [95% confidence interval (CI) 0.48-0.94]. The negative overall association did not differ by gender or by anatomical location. The odds ratio of death from colorectal cancer was 0.64 (95% CI 0.46-0.91) for those screened within 3 years of case diagnosis compared with those not screened. It was 1.14 (95% CI 0.50-2.63) for those screened more than 3 years before case diagnosis. There was a negative association between the risk of death from colorectal cancer and the number of participations in the screening campaigns. The inverse association between screening for faecal occult blood and fatal colorectal cancer suggests that screening can reduce colorectal cancer mortality. This report further supports recommendations for population-based mass screening with faecal occult blood test.  (+info)

Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. (2/590)

BACKGROUND: In 1993, a randomized controlled trial in Minnesota showed, after 13 years of follow-up, that annual fecal occult blood testing was effective in reducing colorectal cancer mortality by at least 33%. Biennial screening (i.e., every 2 years) resulted in only a 6% mortality reduction. Two European trials (in England and in Denmark) subsequently showed statistically significant 15% and 18% mortality reductions with biennial screening. Herein, we provide updated results-through 18 years of follow-up--from the Minnesota trial that address the apparent inconsistent findings among the trials regarding biennial screening. METHODS: From 1976 through 1977, a total of 46551 study subjects, aged 50-80 years, were recruited and randomly assigned to an annual screen, a biennial screen, or a control group. A screen consisted of six guaiac-impregnated fecal occult blood tests (Hemoccult) prepared in pairs from each of three consecutive fecal samples. Participants with at least one of the six tests that were positive were invited for a diagnostic examination that included colonoscopy. All participants were followed annually to ascertain incident colorectal cancers and deaths. RESULTS: The numbers of deaths from all causes were similar among the three study groups. Cumulative 18-year colorectal cancer mortality was 33% lower in the annual group than in the control group (rate ratio, 0.67; 95% confidence interval [CI] = 0.51-0.83). The biennial group had a 21% lower colorectal cancer mortality rate than the control group (rate ratio, 0.79; 95% CI = 0.62-0.97). A marked reduction was also noted in the incidence of Dukes' stage D cancers in both screened groups in comparison with the control group. CONCLUSION: The results from this study, together with the other two published randomized trials of fecal occult blood screening, are consistent in demonstrating a substantial, statistically significant reduction in colorectal cancer mortality from biennial screening.  (+info)

Increasing compliance with colorectal cancer screening: the development of effective health education. (3/590)

The ability of a health education leaflet to raise awareness of the frequency of colorectal cancer and its asymptomatic nature and to increase intention to participate in screening with faecal occult blood testing (FOBT) was investigated. One hundred subjects were interviewed before and after reading the leaflet. The number of men stating bowel cancer was 'very common' increased significantly from 20 to 60% (chi 2 = 16.7, P < 0.0001) and those understanding its asymptomatic nature form 64 to 92% (chi 2 = 11.4, P < 0.001). The leaflet significantly increased the percentage of women reporting bowel cancer as 'very common' from 30 to 70% (chi 2 = 16.0, P < 0.0001) and as being asymptomatic from 58 to 94% (chi 2 = 17.8, P < 0.0001). After reading the leaflet, 55% of men who initially declined screening reversed their decision (chi 2 16.5, P < 0.0001) and 50% of female non-adherers reversed their decision (chi 2 = 17.3, P < 0.0001). Reasons most frequently given for declining colorectal cancer screening were feeling well (77% of subjects declining), concern about further tests (38%), unpleasantness of FOBT (13%) and illness (6%). This leaflet successfully educates people about colorectal cancer and increased intention to participate in screening programmes.  (+info)

Should we be screening for colorectal cancer? (4/590)

Mass population screening for asymptomatic neoplastic disease is now national policy in the UK for breast cancer and has been established for many years in the early diagnosis of carcinoma of the cervix. Cancer screening is based on the concept that treatment is more effective when the disease is localised and aims to detect it when it is at a less advanced clinico-pathological stage prior to the development of symptoms. Because colorectal cancer develops in benign adenomatous polyps which are often amenable to endoscopic resection, screening may both reduce the incidence of the disease as well as improving outcome from it. Flexible sigmoidoscopy screening focuses mainly on the detection of potentially malignant adenomas, their endoscopic removal producing a decrease in colorectal cancer incidence. It is a promising approach but conclusive data on effectiveness from a Medical Research Council-sponsored multicentre randomised controlled trial will not be available before 2006. Faecal occult blood testing aims to preferentially detect early stage invasive disease. Three randomised controlled trials of faecal occult blood screening show that the disease can be detected earlier in its development leading to reduced mortality from the disease--and that this is achieved at reasonable cost. The Department of Health is currently giving consideration to its national implementation.  (+info)

Gastrointestinal safety and tolerance of ibuprofen at maximum over-the-counter dose. (5/590)

BACKGROUND: Delineation of non-steroidal anti-inflammatory drug (NSAID) gastrointestinal toxicity has largely depended on retrospective epidemiologic studies which demonstrate that lower doses of NSAIDs pose a lower risk of gastrointestinal toxicity. Ibuprofen, a propionic acid NSAID, has, in most such studies, exhibited a favourable profile in terms of gastrointestinal bleeding. Since 1984, ibuprofen has been available as a non-prescription analgesic/antipyretic with a limit of 1200 mg/day for 10 days of continuous use. Trials and spontaneously reported adverse experiences suggest that gastrointestinal symptoms and bleeding are rare. METHODS: This study prospectively evaluated the gastrointestinal tolerability, as compared to placebo, of the maximum non-prescription dose and duration of ibuprofen use in healthy subjects representative of a non-prescription analgesic user population. RESULTS: Gastrointestinal adverse experiences were similar in the placebo and ibuprofen groups (67 out of 413, 16% with placebo vs. 161 out of 833, 19% with ibuprofen). There was no difference between the two groups in the proportion discontinuing due to a gastrointestinal event. Gastrointestinal adverse experiences reported by >/= 1% of subjects were: dyspepsia, abdominal pain, nausea, diarrhoea, flatulence, and constipation. Seventeen (1.4%) subjects had positive occult blood tests: their frequency was comparable between treatments. CONCLUSIONS: When used as directed to treat episodic pain, non-prescription ibuprofen at the maximum dose of 1200 mg/day for 10 days, is well-tolerated.  (+info)

Colorectal cancer: risk factors and recommendations for early detection. (6/590)

Spurred by mounting evidence that the detection and treatment of early-stage colorectal cancers and adenomatous polyps can reduce mortality, Medicare and some other payors recently authorized reimbursement for colorectal cancer screening in persons at average risk for this malignancy. A collaborative group of experts convened by the U.S. Agency for Health Care Policy and Research has recommended screening for average-risk persons over the age of 50 years using one of the following techniques: fecal occult blood testing each year, flexible sigmoidoscopy every five years, fecal occult blood testing every year combined with flexible sigmoidoscopy every five years, double-contrast barium enema every five to 10 years or colonoscopy every 10 years. Screening of persons with risk factors should begin at an earlier age, depending on the family history of colorectal cancer or polyps. These recommendations augment the colorectal cancer screening guidelines of the American Academy of Family physicians. Recent advances in genetic research have made it possible to identify persons at high risk for colorectal cancer because of an inherited predisposition to develop this malignancy. These patients require aggressive screening, usually by lower endoscopy performed at an early age. In some patients, genetic testing can guide screening and may be cost-effective.  (+info)

Colorectal cancer prevention. An approach to increasing compliance in a faecal occult blood test screening programme. (7/590)

STUDY OBJECTIVE: The assessment of the uptake of colorectal cancer screening offered in a workplace setting. DESIGN: Employees were offered a free faecal occult blood test (Haemoccult). A repeat letter was sent two months later to non-responders. Those with positive tests were invited for colonoscopy. Compliance was measured according to age, sex, and occupational group and the effects of reinviting non-compliers investigated. SETTING: Leicester General Hospital, a large university teaching hospital. PARTICIPANTS: 990 employees aged 41 to 65 years. MAIN RESULTS: Total compliance was 46% with women participating more than men (49% v 34%, chi 2 = 12.2, p < 0.001). The difference was mostly because of women aged 41 to 50 years complying more than their male counterparts (48% v 24%, chi 2 = 15.5, p < 0.0001). Participation was highest in clinical support staff (56%), nurses (52%), and clerical workers (46%). Uptake by doctors (26%) and managers (26%) was significantly lower than by clinical support staff and nurses (chi 2 > 5.5, p < 0.02). Remailing raised compliance slightly from 43.6% to 46.3%. Four employees (1%) had positive faecal occult blood tests but three were negative on repeat testing with dietary restrictions. CONCLUSIONS: The government favours the development of health promotion programmes as stated in its document "Health at work in the NHS". The response in this study, showed methods to increase compliance must be developed if such programmes are to be successful. As uptake was similar to that in several community based programmes in general practice, workplace based programmes could offer a complementary method of delivering screening.  (+info)

Interval cancers in a randomized controlled trial of screening for colorectal cancer using a faecal occult blood test. (8/590)

BACKGROUND: The sensitivity of unhydrated Haemoccult II has been examined in the context of a randomized controlled trial of faecal occult blood screening for colorectal cancer in Nottingham, UK. METHOD: Both traditional and proportional incidence methods were used to calculate sensitivity separately for both sexes, for two age groups at entry to the trial, for first screen and repeat screens and for three subsites within the large bowel. RESULTS: The traditional method of estimation yielded a sensitivity of 59% whereas the corresponding figure obtained using the proportional incidence method was 54%. The difference between the estimates using the two methods was greatest in subjects aged > or = 65 at entry to the trial and in cancers of the distal colon. CONCLUSIONS: The results suggest that there may be a higher proportion of slower growing tumours in subjects aged > or = 65 and that cancers occurring in the distal colon may have a longer mean sojourn time than cancers proximal to the sigmoid colon.  (+info)

Occult blood refers to the presence of blood in the stool or gastrointestinal tract that is not visible to the naked eye. It is typically detected through chemical tests, such as fecal occult blood tests (FOBT) or fecal immunochemical tests (FIT), which can detect small amounts of blood in the stool. The presence of occult blood may indicate a variety of gastrointestinal conditions, including colorectal cancer, polyps, ulcers, inflammatory bowel disease, and other digestive disorders. It is important to follow up with medical evaluation if occult blood is detected, as early detection and treatment of underlying conditions can improve outcomes.

A colonoscopy is a medical procedure used to examine the large intestine, also known as the colon and rectum. It is performed using a flexible tube with a tiny camera on the end, called a colonoscope, which is inserted into the rectum and gently guided through the entire length of the colon.

The procedure allows doctors to visually inspect the lining of the colon for any abnormalities such as polyps, ulcers, inflammation, or cancer. If any polyps are found during the procedure, they can be removed immediately using special tools passed through the colonoscope. Colonoscopy is an important tool in the prevention and early detection of colorectal cancer, which is one of the leading causes of cancer-related deaths worldwide.

Patients are usually given a sedative to help them relax during the procedure, which is typically performed on an outpatient basis in a hospital or clinic setting. The entire procedure usually takes about 30-60 minutes to complete, although patients should plan to spend several hours at the medical facility for preparation and recovery.

Guaiac, also known as guaiacum, is not a medical term itself but it is related to a diagnostic test in medicine called the Guaiac test or guaiac card test. This test is used to detect the presence of occult blood (blood that is not visible to the naked eye) in stool, which may indicate conditions such as colorectal cancer, polyps, or inflammatory bowel disease.

The Guaiac test works by using a chemical reagent made from the wood of the guaiacum tree, which contains a compound called guaiaconic acid. When this reagent comes into contact with blood, it produces a blue-green color change. The stool sample is placed on a special card treated with the guaiac reagent and then a developer solution is added. If there is blood in the stool, the developer will cause the reagent to turn blue-green.

It's important to note that while a positive Guaiac test can indicate the presence of occult blood in the stool, it does not necessarily mean that there is cancer or other serious condition present. Other factors such as recent ingestion of iron supplements, red meat, or certain vegetables can also cause false-positive results. Therefore, a positive Guaiac test should be followed up with further diagnostic tests to confirm the diagnosis.

Sigmoidoscopy is a medical procedure that involves the insertion of a sigmoidoscope, a flexible tube with a light and camera at the end, into the rectum and lower colon (sigmoid colon) to examine these areas for any abnormalities such as inflammation, ulcers, polyps, or cancer. The procedure typically allows for the detection of issues in the sigmoid colon and rectum, and can help diagnose conditions such as inflammatory bowel disease, diverticulosis, or colorectal cancer.

There are two types of sigmoidoscopy: flexible sigmoidoscopy and rigid sigmoidoscopy. Flexible sigmoidoscopy is more commonly performed because it provides a better view of the lower colon and is less uncomfortable for the patient. Rigid sigmoidoscopy, on the other hand, uses a solid, inflexible tube and is typically used in specific situations such as the removal of foreign objects or certain types of polyps.

During the procedure, patients are usually positioned on their left side with their knees drawn up to their chest. The sigmoidoscope is gently inserted into the rectum and advanced through the lower colon while the doctor examines the lining for any abnormalities. Air may be introduced through the scope to help expand the colon and provide a better view. If polyps or other abnormal tissues are found, they can often be removed during the procedure for further examination and testing.

Sigmoidoscopy is generally considered a safe and well-tolerated procedure. Some patients may experience mild discomfort, bloating, or cramping during or after the exam, but these symptoms typically resolve on their own within a few hours.

Colorectal neoplasms refer to abnormal growths in the colon or rectum, which can be benign or malignant. These growths can arise from the inner lining (mucosa) of the colon or rectum and can take various forms such as polyps, adenomas, or carcinomas.

Benign neoplasms, such as hyperplastic polyps and inflammatory polyps, are not cancerous but may need to be removed to prevent the development of malignant tumors. Adenomas, on the other hand, are precancerous lesions that can develop into colorectal cancer if left untreated.

Colorectal cancer is a malignant neoplasm that arises from the uncontrolled growth and division of cells in the colon or rectum. It is one of the most common types of cancer worldwide and can spread to other parts of the body through the bloodstream or lymphatic system.

Regular screening for colorectal neoplasms is recommended for individuals over the age of 50, as early detection and removal of precancerous lesions can significantly reduce the risk of developing colorectal cancer.

Medical mass screening, also known as population screening, is a public health service that aims to identify and detect asymptomatic individuals in a given population who have or are at risk of a specific disease. The goal is to provide early treatment, reduce morbidity and mortality, and prevent the spread of diseases within the community.

A mass screening program typically involves offering a simple, quick, and non-invasive test to a large number of people in a defined population, regardless of their risk factors or symptoms. Those who test positive are then referred for further diagnostic tests and appropriate medical interventions. Examples of mass screening programs include mammography for breast cancer detection, PSA (prostate-specific antigen) testing for prostate cancer, and fecal occult blood testing for colorectal cancer.

It is important to note that mass screening programs should be evidence-based, cost-effective, and ethically sound, with clear benefits outweighing potential harms. They should also consider factors such as the prevalence of the disease in the population, the accuracy and reliability of the screening test, and the availability and effectiveness of treatment options.

Early detection of cancer refers to the identification of malignant cells or tumors in their initial stages, before they have had a chance to grow and spread. This is typically achieved through various screening methods and tests that are designed to detect specific types of cancers. The goal of early detection is to increase the chances of successful treatment and improve the overall prognosis for patients.

Some common methods used for early cancer detection include:

1. Regular screenings such as mammograms, colonoscopies, and Pap tests, which can help identify precancerous or cancerous cells in their earliest stages.
2. Imaging tests like CT scans, MRIs, and PET scans, which can help detect tumors that may not be visible through other screening methods.
3. Blood tests that look for specific biomarkers or tumor markers, which can indicate the presence of cancer in the body.
4. Genetic testing to identify individuals who may be at higher risk of developing certain types of cancer due to inherited genetic mutations.

It's important to note that while early detection is an important tool in the fight against cancer, it is not a guarantee of successful treatment or cure. However, it can significantly improve the odds of successful treatment and increase the chances of survival for many patients.

Barium sulfate is a medication that is commonly used as a contrast material in medical imaging procedures, such as X-rays and CT scans. It works by coating the inside of the digestive tract, making it visible on an X-ray or CT scan and allowing doctors to see detailed images of the stomach, intestines, and other parts of the digestive system.

Barium sulfate is a white, chalky powder that is mixed with water to create a thick, milky liquid. It is generally safe and does not cause significant side effects when used in medical imaging procedures. However, it should not be taken by individuals who have a known allergy to barium or who have certain digestive conditions, such as obstructions or perforations of the bowel.

It's important to note that while barium sulfate is an important tool for medical diagnosis, it is not a treatment for any medical condition and should only be used under the direction of a healthcare professional.

An enema is a medical procedure in which liquid is introduced into the lower part of the large intestine, specifically the sigmoid colon or rectum, through the anus using a special device called an enema kit. The liquid used can be plain water, saline solution, or a medicated solution, and it is typically retained for a short period of time before being expelled.

The purpose of an enema may vary, but it is often used to relieve constipation, prepare the bowel for medical procedures such as colonoscopy, or administer medications or nutrients that cannot be taken by mouth. Enemas can also be used for therapeutic purposes, such as to stimulate the immune system or promote relaxation.

It is important to follow proper instructions when administering an enema to avoid injury or discomfort. Possible side effects of enemas may include cramping, bloating, nausea, or electrolyte imbalances. If you have any health concerns or conditions that may be affected by an enema, it is recommended to consult with a healthcare professional before using one.

Immunochemistry is a branch of biochemistry and immunology that deals with the chemical basis of antigen-antibody interactions. It involves the application of chemical techniques and principles to the study of immune system components, particularly antibodies and antigens. Immunochemical methods are widely used in various fields such as clinical diagnostics, research, and forensic science for the detection, quantification, and characterization of different molecules, cells, and microorganisms. These methods include techniques like ELISA (Enzyme-Linked Immunosorbent Assay), Western blotting, immunoprecipitation, and immunohistochemistry.

Melena is a medical term that refers to the passage of black, tarry stools. It's not a specific disease but rather a symptom caused by the presence of digested blood in the gastrointestinal tract. The dark color results from the breakdown of hemoglobin, the protein in red blood cells, by gut bacteria and stomach acids.

Melena stools are often associated with upper gastrointestinal bleeding, which can occur due to various reasons such as gastric ulcers, esophageal varices (dilated veins in the esophagus), Mallory-Weiss tears (tears in the lining of the esophagus or stomach), or tumors.

It is essential to differentiate melena from hematochezia, which refers to the passage of bright red blood in the stool, typically indicating lower gastrointestinal bleeding. A healthcare professional should evaluate any concerns related to changes in bowel movements, including the presence of melena or hematochezia.

An adenoma is a benign (noncancerous) tumor that develops from glandular epithelial cells. These types of cells are responsible for producing and releasing fluids, such as hormones or digestive enzymes, into the surrounding tissues. Adenomas can occur in various organs and glands throughout the body, including the thyroid, pituitary, adrenal, and digestive systems.

Depending on their location, adenomas may cause different symptoms or remain asymptomatic. Some common examples of adenomas include:

1. Colorectal adenoma (also known as a polyp): These growths occur in the lining of the colon or rectum and can develop into colorectal cancer if left untreated. Regular screenings, such as colonoscopies, are essential for early detection and removal of these polyps.
2. Thyroid adenoma: This type of adenoma affects the thyroid gland and may result in an overproduction or underproduction of hormones, leading to conditions like hyperthyroidism (overactive thyroid) or hypothyroidism (underactive thyroid).
3. Pituitary adenoma: These growths occur in the pituitary gland, which is located at the base of the brain and controls various hormonal functions. Depending on their size and location, pituitary adenomas can cause vision problems, headaches, or hormonal imbalances that affect growth, reproduction, and metabolism.
4. Liver adenoma: These rare benign tumors develop in the liver and may not cause any symptoms unless they become large enough to press on surrounding organs or structures. In some cases, liver adenomas can rupture and cause internal bleeding.
5. Adrenal adenoma: These growths occur in the adrenal glands, which are located above the kidneys and produce hormones that regulate stress responses, metabolism, and blood pressure. Most adrenal adenomas are nonfunctioning, meaning they do not secrete excess hormones. However, functioning adrenal adenomas can lead to conditions like Cushing's syndrome or Conn's syndrome, depending on the type of hormone being overproduced.

It is essential to monitor and manage benign tumors like adenomas to prevent potential complications, such as rupture, bleeding, or hormonal imbalances. Treatment options may include surveillance with imaging studies, medication to manage hormonal issues, or surgical removal of the tumor in certain cases.

Colonic polyps are abnormal growths that protrude from the inner wall of the colon (large intestine). They can vary in size, shape, and number. Most colonic polyps are benign, meaning they are not cancerous. However, some types of polyps, such as adenomas, have a higher risk of becoming cancerous over time if left untreated.

Colonic polyps often do not cause any symptoms, especially if they are small. Larger polyps may lead to symptoms like rectal bleeding, changes in bowel habits, abdominal pain, or iron deficiency anemia. The exact cause of colonic polyps is not known, but factors such as age, family history, and certain medical conditions (like inflammatory bowel disease) can increase the risk of developing them.

Regular screening exams, such as colonoscopies, are recommended for individuals over the age of 50 to detect and remove polyps before they become cancerous. If you have a family history of colonic polyps or colorectal cancer, your doctor may recommend earlier or more frequent screenings.

Sensitivity and specificity are statistical measures used to describe the performance of a diagnostic test or screening tool in identifying true positive and true negative results.

* Sensitivity refers to the proportion of people who have a particular condition (true positives) who are correctly identified by the test. It is also known as the "true positive rate" or "recall." A highly sensitive test will identify most or all of the people with the condition, but may also produce more false positives.
* Specificity refers to the proportion of people who do not have a particular condition (true negatives) who are correctly identified by the test. It is also known as the "true negative rate." A highly specific test will identify most or all of the people without the condition, but may also produce more false negatives.

In medical testing, both sensitivity and specificity are important considerations when evaluating a diagnostic test. High sensitivity is desirable for screening tests that aim to identify as many cases of a condition as possible, while high specificity is desirable for confirmatory tests that aim to rule out the condition in people who do not have it.

It's worth noting that sensitivity and specificity are often influenced by factors such as the prevalence of the condition in the population being tested, the threshold used to define a positive result, and the reliability and validity of the test itself. Therefore, it's important to consider these factors when interpreting the results of a diagnostic test.

Feces are the solid or semisolid remains of food that could not be digested or absorbed in the small intestine, along with bacteria and other waste products. After being stored in the colon, feces are eliminated from the body through the rectum and anus during defecation. Feces can vary in color, consistency, and odor depending on a person's diet, health status, and other factors.

Gastrointestinal (GI) hemorrhage is a term used to describe any bleeding that occurs in the gastrointestinal tract, which includes the esophagus, stomach, small intestine, large intestine, and rectum. The bleeding can range from mild to severe and can produce symptoms such as vomiting blood, passing black or tarry stools, or having low blood pressure.

GI hemorrhage can be classified as either upper or lower, depending on the location of the bleed. Upper GI hemorrhage refers to bleeding that occurs above the ligament of Treitz, which is a point in the small intestine where it becomes narrower and turns a corner. Common causes of upper GI hemorrhage include gastritis, ulcers, esophageal varices, and Mallory-Weiss tears.

Lower GI hemorrhage refers to bleeding that occurs below the ligament of Treitz. Common causes of lower GI hemorrhage include diverticulosis, colitis, inflammatory bowel disease, and vascular abnormalities such as angiodysplasia.

The diagnosis of GI hemorrhage is often made based on the patient's symptoms, medical history, physical examination, and diagnostic tests such as endoscopy, CT scan, or radionuclide scanning. Treatment depends on the severity and cause of the bleeding and may include medications, endoscopic procedures, surgery, or a combination of these approaches.

Reagent kits, diagnostic are prepackaged sets of chemical reagents and other components designed for performing specific diagnostic tests or assays. These kits are often used in clinical laboratories to detect and measure the presence or absence of various biomarkers, such as proteins, antibodies, antigens, nucleic acids, or small molecules, in biological samples like blood, urine, or tissues.

Diagnostic reagent kits typically contain detailed instructions for their use, along with the necessary reagents, controls, and sometimes specialized equipment or supplies. They are designed to simplify the testing process, reduce human error, and increase standardization, ensuring accurate and reliable results. Examples of diagnostic reagent kits include those used for pregnancy tests, infectious disease screening, drug testing, genetic testing, and cancer biomarker detection.

Computed tomographic colonography (CTC), also known as virtual colonoscopy, is a medical imaging technique that uses computed tomography (CT) scans to produce detailed images of the large intestine (colon) and rectum. In CTC, specialized software creates two- and three-dimensional images of the colon's inner surface, allowing healthcare providers to examine the colon for polyps, tumors, and other abnormalities.

During a CTC procedure, patients are usually given a mild laxative and asked to follow a clear liquid diet beforehand to clean out the colon. A small tube is inserted into the rectum to inflate the colon with air or carbon dioxide, making it easier to visualize any abnormalities. The patient lies on their back and then their stomach while the CT scanner takes multiple images of the abdomen and pelvis from different angles.

CTC has several advantages over traditional colonoscopy, including less invasiveness, lower risk of complications, faster recovery time, and the ability to examine the entire colon without missing any areas. However, if polyps or other abnormalities are detected during a CTC, a follow-up diagnostic colonoscopy may be necessary for removal or further evaluation.

It is important to note that CTC does not replace traditional colonoscopy as a screening tool for colorectal cancer. While it has similar accuracy in detecting large polyps and cancers, its ability to detect smaller polyps is less reliable compared to optical colonoscopy. Therefore, guidelines recommend using CTC as an alternative option for individuals who cannot or do not wish to undergo traditional colonoscopy, or as a supplemental screening tool for those at higher risk of colorectal cancer.

Rectal neoplasms refer to abnormal growths in the tissues of the rectum, which can be benign or malignant. They are characterized by uncontrolled cell division and can invade nearby tissues or spread to other parts of the body (metastasis). The most common type of rectal neoplasm is rectal cancer, which often begins as a small polyp or growth in the lining of the rectum. Other types of rectal neoplasms include adenomas, carcinoids, and gastrointestinal stromal tumors (GISTs). Regular screenings are recommended for early detection and treatment of rectal neoplasms.

Hematologic tests, also known as hematology tests, are a group of diagnostic exams that evaluate the health and function of different components of blood, such as red and white blood cells, platelets, and clotting factors. These tests can detect various disorders, including anemia, infection, bleeding problems, and several types of cancer. Common hematologic tests include complete blood count (CBC), coagulation studies, peripheral smear examination, and erythrocyte sedimentation rate (ESR). The specific test or combination of tests ordered will depend on the patient's symptoms, medical history, and physical examination findings.

Benzidines are a class of chemical compounds with the basic structure of two benzene rings linked by a central nitrogen atom. The term "benzidine" can refer specifically to the parent compound, but it is more commonly used as a general term for a group of related compounds known as benzidine congeners or benzidine derivatives.

Benzidines are primarily used in the manufacture of dyes and pigments, although they have also been used in some industrial and laboratory applications. Exposure to benzidines has been linked to an increased risk of bladder cancer and other health problems, so their use is regulated in many countries.

It's worth noting that the medical definition of "benzidines" primarily focuses on their chemical structure and potential health effects, rather than their specific medical uses or applications.

Indicators and reagents are terms commonly used in the field of clinical chemistry and laboratory medicine. Here are their definitions:

1. Indicator: An indicator is a substance that changes its color or other physical properties in response to a chemical change, such as a change in pH, oxidation-reduction potential, or the presence of a particular ion or molecule. Indicators are often used in laboratory tests to monitor or signal the progress of a reaction or to indicate the end point of a titration. A familiar example is the use of phenolphthalein as a pH indicator in acid-base titrations, which turns pink in basic solutions and colorless in acidic solutions.

2. Reagent: A reagent is a substance that is added to a system (such as a sample or a reaction mixture) to bring about a chemical reaction, test for the presence or absence of a particular component, or measure the concentration of a specific analyte. Reagents are typically chemicals with well-defined and consistent properties, allowing them to be used reliably in analytical procedures. Examples of reagents include enzymes, antibodies, dyes, metal ions, and organic compounds. In laboratory settings, reagents are often prepared and standardized according to strict protocols to ensure their quality and performance in diagnostic tests and research applications.

Patient compliance, also known as medication adherence or patient adherence, refers to the degree to which a patient's behavior matches the agreed-upon recommendations from their healthcare provider. This includes taking medications as prescribed (including the correct dosage, frequency, and duration), following dietary restrictions, making lifestyle changes, and attending follow-up appointments. Poor patient compliance can negatively impact treatment outcomes and lead to worsening of symptoms, increased healthcare costs, and development of drug-resistant strains in the case of antibiotics. It is a significant challenge in healthcare and efforts are being made to improve patient education, communication, and support to enhance compliance.

The Leukocyte L1 Antigen Complex, also known as CD58 or LFA-3 (Lymphocyte Function-Associated Antigen 3), is not a single entity but rather a glycoprotein found on the surface of various cells in the human body, including leukocytes (white blood cells). It plays a crucial role in the immune system's response by interacting with the CD2 receptor on T-cells and natural killer (NK) cells. This interaction helps facilitate cell-to-cell adhesion and activation of T-cells, which are essential for an effective immune response against infections and cancer.

The Leukocyte L1 Antigen Complex is often targeted by certain viruses to evade the host's immune system. For example, some strains of HIV (Human Immunodeficiency Virus) can downregulate the expression of this protein on infected cells, making it harder for the immune system to recognize and eliminate them.

It is important to note that while "Leukocyte L1 Antigen Complex" refers to a specific cell surface protein, CD58 or LFA-3 are alternative names used in the scientific literature to refer to this same protein.

Colonic neoplasms refer to abnormal growths in the large intestine, also known as the colon. These growths can be benign (non-cancerous) or malignant (cancerous). The two most common types of colonic neoplasms are adenomas and carcinomas.

Adenomas are benign tumors that can develop into cancer over time if left untreated. They are often found during routine colonoscopies and can be removed during the procedure.

Carcinomas, on the other hand, are malignant tumors that invade surrounding tissues and can spread to other parts of the body. Colorectal cancer is the third leading cause of cancer-related deaths in the United States, and colonic neoplasms are a significant risk factor for developing this type of cancer.

Regular screenings for colonic neoplasms are recommended for individuals over the age of 50 or those with a family history of colorectal cancer or other risk factors. Early detection and removal of colonic neoplasms can significantly reduce the risk of developing colorectal cancer.

A "false positive reaction" in medical testing refers to a situation where a diagnostic test incorrectly indicates the presence of a specific condition or disease in an individual who does not actually have it. This occurs when the test results give a positive outcome, while the true health status of the person is negative or free from the condition being tested for.

False positive reactions can be caused by various factors including:

1. Presence of unrelated substances that interfere with the test result (e.g., cross-reactivity between similar molecules).
2. Low specificity of the test, which means it may detect other conditions or irrelevant factors as positive.
3. Contamination during sample collection, storage, or analysis.
4. Human errors in performing or interpreting the test results.

False positive reactions can have significant consequences, such as unnecessary treatments, anxiety, and increased healthcare costs. Therefore, it is essential to confirm any positive test result with additional tests or clinical evaluations before making a definitive diagnosis.

Patient acceptance of health care refers to the willingness and ability of a patient to follow and engage in a recommended treatment plan or healthcare regimen. This involves understanding the proposed medical interventions, considering their potential benefits and risks, and making an informed decision to proceed with the recommended course of action.

The factors that influence patient acceptance can include:

1. Patient's understanding of their condition and treatment options
2. Trust in their healthcare provider
3. Personal beliefs and values related to health and illness
4. Cultural, linguistic, or socioeconomic barriers
5. Emotional responses to the diagnosis or proposed treatment
6. Practical considerations, such as cost, time commitment, or potential side effects

Healthcare providers play a crucial role in facilitating patient acceptance by clearly communicating information, addressing concerns and questions, and providing support throughout the decision-making process. Encouraging shared decision-making and tailoring care plans to individual patient needs and preferences can also enhance patient acceptance of health care.

I'm sorry for any confusion, but "Postal Service" is not a term used in medical definitions. It generally refers to the system for delivering mail and packages, such as the United States Postal Service (USPS). If you have any questions about medical terminology or concepts, I'd be happy to help answer those!

The Predictive Value of Tests, specifically the Positive Predictive Value (PPV) and Negative Predictive Value (NPV), are measures used in diagnostic tests to determine the probability that a positive or negative test result is correct.

Positive Predictive Value (PPV) is the proportion of patients with a positive test result who actually have the disease. It is calculated as the number of true positives divided by the total number of positive results (true positives + false positives). A higher PPV indicates that a positive test result is more likely to be a true positive, and therefore the disease is more likely to be present.

Negative Predictive Value (NPV) is the proportion of patients with a negative test result who do not have the disease. It is calculated as the number of true negatives divided by the total number of negative results (true negatives + false negatives). A higher NPV indicates that a negative test result is more likely to be a true negative, and therefore the disease is less likely to be present.

The predictive value of tests depends on the prevalence of the disease in the population being tested, as well as the sensitivity and specificity of the test. A test with high sensitivity and specificity will generally have higher predictive values than a test with low sensitivity and specificity. However, even a highly sensitive and specific test can have low predictive values if the prevalence of the disease is low in the population being tested.

A reminder system in a medical context is a tool or service that helps individuals or healthcare providers remember and adhere to certain health-related tasks or appointments. These systems can be manual, such as written reminders or calendar alerts, or automated, such as electronic messaging services, mobile apps, or wearable devices.

Reminder systems are often used to help patients remember to take their medications at the right time and dose, keep track of medical appointments, perform self-care activities, or monitor their health status. They can also be used by healthcare providers to remind patients about upcoming appointments, follow-up care, or test results.

Effective reminder systems have been shown to improve medication adherence, reduce missed appointments, and enhance overall patient outcomes.

Multiphasic screening is a type of medical testing that involves the administration of several tests or examinations simultaneously or in rapid succession. These screenings can include laboratory tests, imaging studies, physical examinations, and psychological assessments. The goal of multiphasic screening is to efficiently assess an individual's overall health status and identify any potential risk factors, diseases, or conditions that may require further evaluation or treatment.

Multiphasic screening is often used in preventive medicine and public health programs to screen large populations for common health issues such as diabetes, hypertension, high cholesterol, and cancer. The use of multiphasic screening can help identify individuals who are at risk for these conditions before they develop symptoms, allowing for earlier intervention and potentially better outcomes.

It is important to note that while multiphasic screening can provide valuable information about an individual's health status, it is not a substitute for regular medical check-ups and consultations with healthcare professionals. Any abnormal results from a multiphasic screening should be followed up with further testing and evaluation by a qualified healthcare provider.

Immunologic tests are a type of diagnostic assay that detect and measure the presence or absence of specific immune responses in a sample, such as blood or tissue. These tests can be used to identify antibodies, antigens, immune complexes, or complement components in a sample, which can provide information about the health status of an individual, including the presence of infection, autoimmune disease, or immunodeficiency.

Immunologic tests use various methods to detect these immune components, such as enzyme-linked immunosorbent assays (ELISAs), Western blots, immunofluorescence assays, and radioimmunoassays. The results of these tests can help healthcare providers diagnose and manage medical conditions, monitor treatment effectiveness, and assess immune function.

It's important to note that the interpretation of immunologic test results should be done by a qualified healthcare professional, as false positives or negatives can occur, and the results must be considered in conjunction with other clinical findings and patient history.

"Trichuris" is a genus of parasitic roundworms that are known to infect the intestines of various mammals, including humans. The species that commonly infects humans is called "Trichuris trichiura," which is also known as the human whipworm. These worms are named for their long, thin shape that resembles a whip.

The life cycle of Trichuris involves ingestion of eggs containing infective larvae through contaminated food or water. Once inside the human body, the larvae hatch and migrate to the large intestine, where they mature into adult worms that live in the caecum and colon. Adult female worms lay thousands of eggs every day, which are passed in the feces and can survive in the environment for years, waiting to infect a new host.

Infections with Trichuris trichiura can cause symptoms such as diarrhea, abdominal pain, bloating, and weight loss. In severe cases, it can lead to anemia, malnutrition, and impaired growth in children. Treatment for trichuriasis typically involves medication that kills the adult worms, such as albendazole or mebendazole.

Hemoglobin (Hb or Hgb) is the main oxygen-carrying protein in the red blood cells, which are responsible for delivering oxygen throughout the body. It is a complex molecule made up of four globin proteins and four heme groups. Each heme group contains an iron atom that binds to one molecule of oxygen. Hemoglobin plays a crucial role in the transport of oxygen from the lungs to the body's tissues, and also helps to carry carbon dioxide back to the lungs for exhalation.

There are several types of hemoglobin present in the human body, including:

* Hemoglobin A (HbA): This is the most common type of hemoglobin, making up about 95-98% of total hemoglobin in adults. It consists of two alpha and two beta globin chains.
* Hemoglobin A2 (HbA2): This makes up about 1.5-3.5% of total hemoglobin in adults. It consists of two alpha and two delta globin chains.
* Hemoglobin F (HbF): This is the main type of hemoglobin present in fetal life, but it persists at low levels in adults. It consists of two alpha and two gamma globin chains.
* Hemoglobin S (HbS): This is an abnormal form of hemoglobin that can cause sickle cell disease when it occurs in the homozygous state (i.e., both copies of the gene are affected). It results from a single amino acid substitution in the beta globin chain.
* Hemoglobin C (HbC): This is another abnormal form of hemoglobin that can cause mild to moderate hemolytic anemia when it occurs in the homozygous state. It results from a different single amino acid substitution in the beta globin chain than HbS.

Abnormal forms of hemoglobin, such as HbS and HbC, can lead to various clinical disorders, including sickle cell disease, thalassemia, and other hemoglobinopathies.

I'm sorry for any confusion, but "Philippines" is not a medical term. It is the name of a country located in Southeast Asia, comprised of over 7,000 islands. If you have any questions about medical conditions or terms, I would be happy to help clarify those for you.

Cost-benefit analysis (CBA) is a systematic process used to compare the costs and benefits of different options to determine which one provides the greatest net benefit. In a medical context, CBA can be used to evaluate the value of medical interventions, treatments, or policies by estimating and monetizing all the relevant costs and benefits associated with each option.

The costs included in a CBA may include direct costs such as the cost of the intervention or treatment itself, as well as indirect costs such as lost productivity or time away from work. Benefits may include improved health outcomes, reduced morbidity or mortality, and increased quality of life.

Once all the relevant costs and benefits have been identified and quantified, they are typically expressed in monetary terms to allow for a direct comparison. The option with the highest net benefit (i.e., the difference between total benefits and total costs) is considered the most cost-effective.

It's important to note that CBA has some limitations and can be subject to various biases and assumptions, so it should be used in conjunction with other evaluation methods to ensure a comprehensive understanding of the value of medical interventions or policies.

A "false negative" reaction in medical testing refers to a situation where a diagnostic test incorrectly indicates the absence of a specific condition or disease, when in fact it is present. This can occur due to various reasons such as issues with the sensitivity of the test, improper sample collection, or specimen handling and storage.

False negative results can have serious consequences, as they may lead to delayed treatment, misdiagnosis, or a false sense of security for the patient. Therefore, it is essential to interpret medical test results in conjunction with other clinical findings, patient history, and physical examination. In some cases, repeating the test or using a different diagnostic method may be necessary to confirm the initial result.

Colonic diseases refer to a group of medical conditions that affect the colon, also known as the large intestine or large bowel. The colon is the final segment of the digestive system, responsible for absorbing water and electrolytes, and storing and eliminating waste products.

Some common colonic diseases include:

1. Inflammatory bowel disease (IBD): This includes conditions such as Crohn's disease and ulcerative colitis, which cause inflammation and irritation in the lining of the digestive tract.
2. Diverticular disease: This occurs when small pouches called diverticula form in the walls of the colon, leading to symptoms such as abdominal pain, bloating, and changes in bowel movements.
3. Colorectal cancer: This is a type of cancer that develops in the colon or rectum, often starting as benign polyps that grow and become malignant over time.
4. Irritable bowel syndrome (IBS): This is a functional gastrointestinal disorder characterized by abdominal pain, bloating, and changes in bowel movements, but without any underlying structural or inflammatory causes.
5. Constipation: This is a common condition characterized by infrequent bowel movements, difficulty passing stools, or both.
6. Infectious colitis: This occurs when the colon becomes infected with bacteria, viruses, or parasites, leading to symptoms such as diarrhea, abdominal cramps, and fever.

Treatment for colonic diseases varies depending on the specific condition and its severity. Treatment options may include medications, lifestyle changes, surgery, or a combination of these approaches.

I'm sorry for any confusion, but "United States" is a geopolitical entity, specifically the name of the country consisting of 50 states, and it is not a medical term or concept. Therefore, I can't provide a medical definition for it. If you have any questions related to health, medicine, or biology, I would be happy to try to help answer those!

Gastroenterology is a branch of medicine that deals with the study, diagnosis, management, and treatment of disorders and diseases of the digestive system, also known as the gastrointestinal (GI) tract. This includes the esophagus, stomach, small intestine, large intestine (colon), liver, pancreas, gallbladder, and bile ducts.

Physicians who specialize in this field are called gastroenterologists. They undergo extensive training in internal medicine and then complete a fellowship in gastroenterology, where they gain expertise in using various diagnostic techniques such as endoscopy, colonoscopy, and radiologic imaging to evaluate GI tract disorders.

Gastroenterologists treat a wide range of conditions affecting the digestive system, including but not limited to:

1. Gastroesophageal reflux disease (GERD)
2. Inflammatory bowel disease (IBD), which includes Crohn's disease and ulcerative colitis
3. Irritable bowel syndrome (IBS)
4. Celiac disease
5. Hepatitis and other liver diseases
6. Pancreatic disorders, such as pancreatitis
7. Gastrointestinal cancers, like colon, rectal, and esophageal cancer
8. Functional gastrointestinal disorders (FGIDs), which include chronic abdominal pain, bloating, and difficulty with bowel movements

By focusing on the prevention, diagnosis, and treatment of digestive diseases, gastroenterologists play a crucial role in maintaining overall health and well-being for their patients.

Occult blood may refer to: Fecal occult blood, blood present in the feces that is not visibly apparent Hematuria, the presence ... of red blood cells in the urine This disambiguation page lists articles associated with the title Occult blood. If an internal ...
Blood in stool may be a sign of hemorrhoids, colorectal cancer, or another condition. Learn more. ... A fecal occult blood test looks for blood in the stool. ... What is a Fecal Occult Blood Test?. A fecal occult blood test ( ... Why do I need a fecal occult blood test?. Your health care provider may order a fecal occult blood test if you have symptoms of ... There are two main types of fecal occult blood tests:. *The guaiac fecal occult blood test (gFOBT) uses a chemical (guaiac) to ...
... Ann Intern Med. 2009 Feb 3; ... Background: Different immunochemical fecal occult blood tests (FOBTs) have been proposed for noninvasive colorectal cancer ...
... World J Hepatol 2013; 5(2): 64-73 [PMID: 23646231 DOI: 10.4254/ ... Occult hepatitis B virus infection among Egyptian blood donors. World J Hepatol 2013; 5(2): 64-73 ... Figure 2 Prevalence of hepatitis B virus-DNA among blood donors with different antibodies to hepatitis B surface levels. Anti- ... Figure 1 Prevalence of antibodies to hepatitis B core among hepatitis B surface antigen negative blood donors in different age ...
In the analysis of the whole group, both the actual and occult blood loss volume were lower in the tranexamic acid group (both& ... Tranexamic acid reduced occult blood loss and tourniquet time in the obese group (P < 0.05), while no such effects were ... Tranexamic acid can reduce occult blood loss and tourniquet time in obese patients to a greater extent than in patients of ... We hypothesized that tranexamic acid would reduce blood loss to a greater extent in obese patients than in those of normal ...
Troubled Blood: Talbots Thyroid and Rowlings Occult Artistry and Meaning. March 20, 2021 by John 6 Comments ... I would really like to hear some responses to this issue if the occult in troubled blood.. Besides for the thyroid idea, Im ... In Troubled Blood the Seeker asks the Sage mid-book "Is it real?" and the older and supposedly wiser partner says, "Hell no." ... Deo volente, I will be writing this week about the mythological elements in Troubled Blood and The Faerie Queen, an epic ...
Clinical Trial: Colorectal Cancer Screening in Average-Risk Population: Immunochemical Fecal Occult Blood Testing Versus ... Close more info about Clinical Trial: Colorectal Cancer Screening in Average-Risk Population: Immunochemical Fecal Occult Blood ... Close more info about Clinical Trial: Colorectal Cancer Screening in Average-Risk Population: Immunochemical Fecal Occult Blood ... Close more info about Clinical Trial: Colorectal Cancer Screening in Average-Risk Population: Immunochemical Fecal Occult Blood ...
Comparison of CT colonography, colonoscopy, sigmoidoscopy and faecal occult blood tests for the detection of advanced adenoma ... Comparison of CT colonography, colonoscopy, sigmoidoscopy and faecal occult blood tests for the detection of advanced adenoma ...
Stool Occult Blood Tests - Explore from the MSD Manuals - Medical Consumer Version. ... called occult blood). The detection of such small amounts of blood may provide an early clue that ulcers, cancers, or other ... a protein in red blood cells that gives blood its red color) to detect blood in the stool. For this test, people collect ... Chemicals can be used to detect small amounts of blood in the stool... read more ). People collect stool samples for this test ...
Aged Colorectal Neoplasms Connecticut Female Health Promotion Humans Male Mass Media Mass Screening Middle Aged Occult Blood ... 1992). Detecting colorectal cancer with a large scale fecal occult blood testing program.. 107(3). Gregorio, D I and Lolachi, P ... "Detecting colorectal cancer with a large scale fecal occult blood testing program." vol. 107, no. 3, 1992. Export RIS Citation ... The researchers analyzed outcome data for 439 persons who had positive fecal occult blood tests in a 1984 statewide program for ...
Fecal Occult Blood Test Triple Slides. $74.35. - $509.85. Select options. * Seracult® Plus Single Slides Fecal Occult Blood ... Single Slides Fecal Occult Blood Test. $46.15. - $472.45. Select options. * Seracult® Plus Triple Slides Fecal Occult Blood ...
... document about melena vs occult blood,download an entire melena vs occult blood document onto your computer. ... Fecal Occult Blood Test - Quest Diagnostics. https://online.documentine.com/melena-vs-occult-blood/1/fecal-occult-blood-test- ... Fecal Occult Blood Test - Quest Diagnostics. https://online.documentine.com/melena-vs-occult-blood/1/fecal-occult-blood-test- ... Fecal Occult Blood Test Coverage Indications, Limitations, and/or Medical Necessity The Fecal Occult Blood Test (FOBT) detects ...
Blood in the stool is a sign of bleeding in the digestive tract. ... A fecal occult blood test checks a stool sample for blood that ...
Fecal Occult Blood. By ,August 8, 2022,Comments Off on Fecal Occult Blood ...
Two occultists use a bowl of blood to summon a blood elemental/demon and the spirit of a dead torturer. ... The Blood Elemental: An Occult Tale I am not a student or a fan of Occultism. Its workings are too theoretical, too elevated ... "but being men of blood it may be possible to find them by means of the blood elementals." ... In TAOAMO, Bland writes: "In 1913 a well-known student of occult matters announced this theory of Protective Vibrations." He ...
fecal occult blood test October 19, 2021. /in questions /by developer. Table of Contents ... A false-positive result with the fecal occult blood test can result from:. ingestion of large amounts of vitamin C. a high ... A false-positive result with the fecal occult blood test can result from: ... 0 0 developer developer2021-10-19 13:01:272021-10-19 13:01:27fecal occult blood test. ...
Fecal occult blood test This test checks a stool sample for hidden blood. Small amounts of blood can be in the stool when ... Please refer to your physician for more information about procedure risks related to fecal occult blood test which include risk ... 6 If results are positive for blood, further testing is needed to find the exact cause of bleeding.3 Often individuals perform ...
Be the first to review "(FOB) Fecal Occult Blood Test Cassette FOB-F02D" Cancel reply. Your email address will not be published ... Home Diagnostic Reagent Tumor Marker Test Kits (FOB) Fecal Occult Blood Test Cassette FOB-F02D ... The One Step Fecal Occult Blood Test Cassette is a simple, direct binding immunoassay for the rapid and. qualitative detection ... of human occult blood in feces. The assay is designed to detect lower levels of. colorectal bleeding than other biochemical ...
Detection of occult blood at crime scenes against life, acts as a control tool in hygienic processes in Health Sector or ... Once detected by occult blood Luminol how to proper clean?. * For efficient removal of occult blood is necessary to use ... Once detected occult blood by Luminol how to proper clean? *For efficient removal of occult blood is necessary to use ... Detection of blood burned in accidental and criminal explosions. *Detection of occult blood without the use conditions of total ...
Occult Dark Goth Drop Earring Jewelry Blood Rose Heart Oil Bat Gothic Earrings For Womens Retro Hanging Long Earings Aesthetic ... 2021 Goth Earring Occult Dark Jewelry Blood Rose Heart Gothic Long Aesthetic Earrings. Regular price $7.54. $7.54 Available ... Occult Dark Goth Drop Earring Jewelry Blood Rose Heart Oil Bat Gothic Earrings For Womens Retro Hanging Long Earings Aesthetic ... 2021 Goth Earring Occult Dark Jewelry Blood Rose Heart Gothic Long Aesthetic Earrings ...
Warfarin Use During Fecal Occult Blood Testing: A Meta-Analysis ...
Bring a bold edge to your accessory game with our Blood Galore Distressed Baseball Cap. This cap is designed to make a ... The Blood Galore Distressed Baseball Cap is more than just headwear - its an attitude, a testament to the bold, and a nod to ... Bring a bold edge to your accessory game with our Blood Galore Distressed Baseball Cap. This cap is designed to make a ... So, step into the spotlight, don your Blood Galore Distressed Baseball Cap, and let your style speak volumes. ...
Fecal Occult Blood (FOBT) Rapid Diagnostic Test 2022-2030 Market Research, Market Analysis, CAGR, Growth Trends, Key Players, ... 2022-2030 Global and Regional Fecal Occult Blood (FOBT) Rapid Diagnostic Test Industry Production, Sales and Consumption Status ...
... occult) blood in stool samples. The fecal occult blood test is also known as stool occult blood, immunoassay FOBT, hemoccult, ... Europe fecal occult blood tests market is expected to gain market growth in the forecast period of 2023 to 2030. Data Bridge ... Europe Fecal Occult Blood Tests Market Key Players, Size, Share, Growth, Trends and Opportunities. ... On the basis of test type, the Europe fecal occult blood tests market is segmented into lateral flow immuno-FOB test kits, ...
2348034806218∆¢∆HOW TO JOIN OCCULT FOR INSTANT MONEY RITUAL WITHOUT HUMAN BLOOD∆¢ ... 2348034806218∆¢∆HOW TO JOIN OCCULT FOR INSTANT MONEY RITUAL WITHOUT HUMAN BLOOD∆¢ ... 2348034806218∆¢∆HOW TO JOIN OCCULT FOR INSTANT MONEY RITUAL WITHOUT HUMAN BLOOD∆¢ ... 2348034806218∆¢∆HOW TO JOIN OCCULT FOR INSTANT MONEY RITUAL WITHOUT HUMAN BLOOD∆¢ ...
We use cookies to ensure that we give you the best experience on our website. If you click Accept all cookies well assume that you are happy to receive all cookies and you wont see this message again. If you click Reject all non-essential cookies only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click Find out more for information on how to change your cookie settings. ...
Blood Wizards Occult Video. The Wizard gives you a peak behind the curtain at their sacred rituals for sparking sessions and ... Nolan Miskells Blood Wizard Part. Nolan hops out the gate with an earth-shaking slam, then proceeds to attack spot after ... Blood Wizard: Carmel Valley Park Rips. Chris Gregson, Tristan Rennie, Riley Wiley, Conner Norris and Nolan Miskell took it out ... TJ Rogers finds a home on éS, Gabriel and Wacsons Grow part, Nolan Miskells Blood Wizard part, UMAs Punch a Hole in the Sky ...
... clearance for a fecal occult blood screen test (ForSure) and a multifunction analyzer (Trilogy); and the FDA has approved a ... Fecal Occult Blood Screen Test ( ForSure) for Detection of Colorectal Disease On May 11, the FDA granted 510(k) clearance for a ... July 31, 2007 - The US Food and Drug Administration (FDA) has granted 510(k) clearance for a fecal occult blood screen test for ... Cite this: Jill Taylor . FDA Device Clearances: Fecal Occult Blood Screen Test, Multifunction Analyzer, Ceramic Articulation ...
  • A fecal occult blood test (FOBT) looks at a sample of your stool (poop) to check for blood. (medlineplus.gov)
  • Discontinued Availability of Guaiac Fecal Occult Blood Testing (gFOBT) To all Physicians and Health Providers Effective January 1st 2014, the guaiac FOBT (gFOBT) will no longer be available for use in community health care settings. (documentine.com)
  • Fecal Occult Blood Test Coverage Indications, Limitations, and/or Medical Necessity The Fecal Occult Blood Test (FOBT) detects the presence of trace amounts of blood in stool. (documentine.com)
  • In 2008, the U.S. Preventive Services Task Force (USPSTF) recommended that persons aged 50-75 years at average risk for colorectal cancer be screened by using one or more of the following methods: high-sensitivity fecal occult blood testing (FOBT) every year, sigmoidoscopy every 5 years with FOBT every 3 years, or colonoscopy every 10 years ( 2 ). (cdc.gov)
  • Every 2 years (in even-numbered years) respondents aged ≥50 years are asked whether they have ever used a "special kit at home to determine whether the stool contains blood (FOBT)," whether they have ever had "a tube inserted into the rectum to view the colon for signs of cancer or other health problems (sigmoidoscopy or colonoscopy)," and when these tests were last performed. (cdc.gov)
  • A 2004 state-specific CRC screening module for the Behavioral Risk Factor Surveillance System (BRFSS) survey asked 3,355 participants aged 50 years or older why they had not ever or had not recently completed a fecal occult blood test (FOBT) or lower endoscopy. (cdc.gov)
  • For average-risk adults aged 50 or older, the fecal occult blood test (FOBT) is recommended annually, flexible sigmoidoscopy every 5 years, and colonoscopy every 10 years (3). (cdc.gov)
  • Detecting colorectal cancer with a large scale fecal occult blood testing program. (cdc.gov)
  • Fecal occult blood testing was negative. (hindawi.com)
  • A fecal occult blood test can screen for colorectal cancer to help find the disease early when treatment may be most effective. (medlineplus.gov)
  • A fecal occult blood test is commonly used as a screening test to help find colorectal cancer before you have symptoms. (medlineplus.gov)
  • A fecal occult blood test is one or several types of colorectal screening tests. (medlineplus.gov)
  • Different immunochemical fecal occult blood tests (FOBTs) have been proposed for noninvasive colorectal cancer screening. (nih.gov)
  • July 31, 2007 - The US Food and Drug Administration (FDA) has granted 510(k) clearance for a fecal occult blood screen test for the detection of colorectal disease and a multifunction analyzer for diagnostic testing. (medscape.com)
  • On May 11, the FDA granted 510(k) clearance for a fecal occult blood screen test ( ForSure , Aventir Biotech LLC) for the detection of possible colorectal carcinoma, Crohn's disease, ulcerative colitis, and colon polyps in humans. (medscape.com)
  • Faecal occult blood loss accurately predicts future detection of colorectal cancer. (bvsalud.org)
  • Occult blood may refer to: Fecal occult blood, blood present in the feces that is not visibly apparent Hematuria, the presence of red blood cells in the urine This disambiguation page lists articles associated with the title Occult blood. (wikipedia.org)
  • The One Step Fecal Occult Blood Test Cassette is a simple, direct binding immunoassay for the rapid and qualitative detection of human occult blood in feces. (aiconbiotech.com)
  • The fecal immunochemical test (iFOBT or FIT) uses antibodies to find blood in stool. (medlineplus.gov)
  • The fecal immunochemical test (FIT) uses antibodies directed against human hemoglobin (a protein in red blood cells that gives blood its red color) to detect blood in the stool. (msdmanuals.com)
  • The blood stool or occult blood test, or fecal immunochemical or FIT test, are tests to determine whether you have blood in your stool or bowel movement. (cdc.gov)
  • The screening test for bowel cancer is called a Faecal Occult Blood (FOB) test and analyses samples of bowel motions for tiny traces of blood that may be invisible to the naked eye. (nnuh.nhs.uk)
  • Polyps and bowel cancers sometimes bleed, and the faecal occult blood (FOB) test works by detecting tiny amounts of blood which cannot normally be seen in bowel motions. (nnuh.nhs.uk)
  • The device was designed as a blood chemistry analyzer for the quantitative determination of glucose, creatinine, and urea nitrogen in serum. (medscape.com)
  • Creatinine and blood urea nitrogen measurements are used in the diagnosis and treatment of renal diseases and in monitoring renal function. (medscape.com)
  • Chemicals can be used to detect small amounts of blood in the stool that are too small to be seen or change the appearance of stool (called occult blood). (msdmanuals.com)
  • Chemicals can be used to detect small amounts of blood in the stool. (msdmanuals.com)
  • This test checks a stool sample for hidden blood. (medtronic.com)
  • What is a Fecal Occult Blood Test? (medlineplus.gov)
  • But a fecal occult blood test alone cannot diagnose any condition. (medlineplus.gov)
  • If your test results show blood in your stool, you will likely need other tests to diagnose the exact cause. (medlineplus.gov)
  • Your health care provider may order a fecal occult blood test if you have symptoms of a condition that could involve bleeding in your digestive tract. (medlineplus.gov)
  • This test checks your stool for blood and cells with genetic changes that may be a sign of cancer. (medlineplus.gov)
  • The guaiac fecal occult blood test (gFOBT) uses a chemical (guaiac) to find blood in stool. (medlineplus.gov)
  • For this test, a chemical called guaiac is used to detect blood in the stool. (msdmanuals.com)
  • Please refer to your physician for more information about procedure risks related to fecal occult blood test which include risk of false-negative and false-positive results. (medtronic.com)
  • Did your doctor or other health professional describe the ADVANTAGES of the blood stool or FIT test as an option to check for colon cancer? (cdc.gov)
  • Have you EVER HAD a blood stool test, using a HOME test kit? (cdc.gov)
  • Have you had a HOME blood stool test in the LAST 3 YEARS where the results were NOT normal? (cdc.gov)
  • Have you EVER been given a HOME blood stool test kit that you did not complete and return to the doctor or laboratory? (cdc.gov)
  • The CA-125 blood test is not recommended as a large-scale screening for ovarian cancer. (cancerquest.org)
  • Is it a fecal occult blood screening test? (who.int)
  • If blood is detected, further tests are needed to determine the source. (msdmanuals.com)
  • There are, however, yet other kinds of occult or Satanist groups which actively encourage immorality and criminal acts against others and may set 'tests' for members which involve deliberate transgression to break down 'Christian' standards or morality and decency. (christianity.org.uk)
  • Transmission of infection within a dental surgery may occur by direct contact of tissue with secretions or blood, from droplets containing infectious agent, or via contaminated sharps or instruments which have been improperly sterilized. (who.int)
  • Dental surgery assistants, who are involved in the treatment of patients, cleaning of instruments and surgery disinfection, should also wear gloves, because their hands are considered to be a major source of infection [9], and potentially infected blood may be harboured beneath the fingernails for up to five days [10]. (who.int)
  • Blood glucose using certain devices cleared by the Food and Drug Administration (FDA) specifically for home use. (cdc.gov)
  • Figure 2 Prevalence of hepatitis B virus-DNA among blood donors with different antibodies to hepatitis B surface levels. (wjgnet.com)
  • Figure 3 Results of antibodies to hepatitis B core, antibodies to hepatitis B surface and hepatitis B virus DNA among the studied blood donors. (wjgnet.com)
  • Figure 1 Prevalence of antibodies to hepatitis B core among hepatitis B surface antigen negative blood donors in different age groups. (wjgnet.com)
  • Talbot's son Gregory explains to Strike in Troubled Blood that Mrs Talbot had him "sectioned," that is " detained under a 'section' (paragraph) of the Mental Health Act 1983 , " because of his claim that he had successfully invoked the Whore of Babylon and that doctors discovered he was suffering from an "overactive thyroid. (hogwartsprofessor.com)
  • I'm pretty sure that Rowling-Galbraith, in making her astrology and tarot consumed detective suffer from an "overactive thyroid," is playing with the occult community's 'received opinion' (via Manly Hall and others) that the pineal gland is the Eye of God and the locus of human contact with the psychic realm. (hogwartsprofessor.com)
  • Small amounts of blood can be in the stool when polyps or cancers start to form. (medtronic.com)
  • The detection of such small amounts of blood may provide an early clue that ulcers, cancers, or other abnormalities are present. (msdmanuals.com)
  • Occult blood means that you can't see it with the naked eye. (medlineplus.gov)
  • Blood in your stool means there is bleeding in the digestive tract . (medlineplus.gov)
  • In the last months of 1974 and the first months of 1975, he used occult means, principally astrology and tarot cards but also invocational magic in the end, in order to find the missing general practitioner or to reveal her killer. (hogwartsprofessor.com)
  • Why did Talbot's excess thyroxin result in his discarding pretty much everything he knew about how to investigate a case professionally and pursue occult means instead? (hogwartsprofessor.com)
  • It will not be an easy task to find them," he said, "but being men of blood it may be possible to find them by means of the blood elementals. (hauntedohiobooks.com)
  • Occult' means hidden. (nnuh.nhs.uk)
  • 6 If results are positive for blood, further testing is needed to find the exact cause of bleeding. (medtronic.com)
  • 3 See http://www.who.int/nmh/events/2015/bloomberg-data-for-health/en/ (accessed 10 October 2016). (who.int)
  • So doctors might talk about 'occult' blood in samples where the blood can't be seen but it still there. (christianity.org.uk)
  • Why do you have to sell your kidneys for money and treasure, why not save your time and join the moving train today without human blood or fresh, joining the the Zeruzandah Brotherhood in Nigeria brings you into the land of the riches where all heart desires is guarantee in less than thirty days (30). (merakispainc.com)
  • Obesity can result in increased blood loss, which is correlated with poor prognosis in total knee arthroplasty (TKA). (dovepress.com)
  • Clinical application of tranexamic acid is effective in reducing blood loss in TKA. (dovepress.com)
  • http://www.un.org/en/ga/search/view_doc.asp?symbol=A/RES/68/300 (accessed 10 October 2016). (who.int)
  • on the evaluation and management of occult and obscure gastrointestinal bleeding. (documentine.com)
  • We first investigated the ability of intravenous tranexamic acid to reduce intraoperative blood loss in knee osteoarthritis patients undergoing unilateral TKA. (dovepress.com)
  • Tranexamic acid can reduce occult blood loss and tourniquet time in obese patients to a greater extent than in patients of normal weight. (dovepress.com)
  • The detective was put on medication for hyperthyroidism which helped him recover his wits and his disdain for the occult but not in time to save his career. (hogwartsprofessor.com)
  • We hypothesized that tranexamic acid would reduce blood loss to a greater extent in obese patients than in those of normal weight. (dovepress.com)
  • Previous studies showed that TKA is likely to cause a large amount of perioperative blood loss. (dovepress.com)
  • 4 Obesity aggravates this situation and can give rise to greater blood loss, which is correlated with a poor prognosis in surgical patients. (dovepress.com)
  • A second liquid chemical (peroxidase) is added, and the sample changes color if blood is present. (msdmanuals.com)

No images available that match "occult blood"